ArticleAnnals of hematology2024

Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study.

Ivo Demel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.